Skip to main content

James Mahony, Katherine Andrews-Cramer, Dave Oehler, Karin Eastham


Tm Bioscience has appointed James Mahony to its scientific advisory board, effective immediately. According to Tm, the SAB “meets regularly to advise management on the selection and development of new DNA-based diagnostic products and provide recommendations on regulatory and commercialization strategies for the company’s growing menu of genetic tests.”

Mahony is currently director of the McMaster University Regional Virology and Chlamydiology Laboratory at St. Joseph’s Healthcare in Hamilton, Ontario, and is a professor in the department of pathology and molecular medicine at the university. He is a member of the Canadian Society of Microbiologists, the Canadian Association of Clinical Microbiology and Infectious Diseases, and is a fellow of the American Academy of Microbiology.

Mahony received a PhD in molecular biology from the University of Toronto in 1978.

Integrated Genomics has hired Katherine Andrews-Cramer as director for business development, and Dave Oehler as director for marketing and sales, the company said last week.

Andrews-Cramer joins the company from Argenta Discovery, where she was vice president for business development. She has a PhD in biochemistry from the University of Illinois at Urbana-Champaign and a BA in biology from Lake Forest College in Lake Forest, Ill.

Oehler was most recently director of sales for MiraiBio, a Hitachi Software company. He holds a BA in human biology from Stanford University.

Karin Eastham has become executive vice president and chief operating officer of the Burnham Institute, the La Jolla, Calif.-based research center said on Monday. She will also join the institute’s board of trustees. Eastham joins the Burnham Institute from Diversa, where she was senior vice president for finance, CFO, and secretary. She earned an MBA and a BS from Indiana University and is a certified public accountant.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.